A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer

NCT07031154 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Adebrelimab
Apatinib

Interventions

DRUG: Adebrelimab
DRUG: Apatinib

Sponsor

The First Affiliated Hospital of Xiamen University